July 27, 2017 Clinical Research/Diagn. Life Science Tools PR/Corporate Product Launch

Unique concept of MDx, Seegene Random Access System, announced at AACC 2017

Seoul, South Korea – July 26, 2017 – Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the “System”) at the 69th AACC Annual Clinical Lab Expo in San Diego, CA, from July 30 to August 3. The ‘Seegene Random Access... Read more

July 25, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Agilent Technologies Introduces Real-Time PCR System for Clinical Diagnostics in Europe

AriaDx Provides Modular Solution for Diagnostic Labs and Assay Developers SANTA CLARA, Calif., July 25, 2017 Agilent Technologies Inc. (NYSE: A) today expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic... Read more

July 19, 2017 Clinical Research/Diagn. M&A, Partnerships

GE Healthcare Acquires Novia Strategies to expand Clinical Consulting Capabilities and Help More Healthcare Organizations Achieve Breakthrough Outcomes

July 10, 2017 – GE Healthcare (NYSE:GE) announced today it is expanding its U.S. healthcare consulting business with the acquisition of Novia Strategies, a 22-year-old healthcare consulting firm founded and led by clinicians with deep experience helping organizations transform while delivering critical outcomes.  The acquisition helps GE Healthcare deliver on its commitment to be the... Read more

July 19, 2017 Acad, Gov/Utilities Clinical Research/Diagn. Microscopy PR/Corporate Product Launch

BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System

FRANKLIN LAKES, N.J., July 19, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD FACSLyric™ flow cytometer system, an easy-to-use in vitro diagnostic (IVD) system, for use with BD Multitest™ assays... Read more

July 19, 2017 Cell Analysis Tools Clinical Research/Diagn.

BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System

BD FACSLyric™ Flow Cytometer System with BD Multitest™ Assays Offers Reliability and Consistency Jul 19, 2017 FRANKLIN LAKES, N.J., July 19, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD FACSLyric™... Read more

July 13, 2017 Clinical Research/Diagn.

BioLife Solutions CryoStor® Cell Freeze Media Embedded in Invossa™: First Approved Cell and Gene Therapy for Osteoarthritis

Korean Approval Received by Kolon Life Science, TissueGene’s Exclusive Licensee BOTHELL, Wash., July 13, 2017 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), the leading supplier of pre-formulated, clinical grade cell and tissue hypothermic storage and cryopreservation freeze media (“BioLife”), today announced that Kolon Life Science, TissueGene’s exclusive licensee for Asia, including Korea, has received marketing approval for Invossa-K Inj., the world’s first cell and... Read more

July 6, 2017 Clinical Research/Diagn. Life Science Tools

Promega Intends to Seek FDA Approval for Microsatellite Instability Assay to Assist in Strategic Cancer Decisions

MADISON, WI USA (July 6, 2017) Promega Corporation intends to seek US Food and Drug Administration approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. MSI status is a measure of mismatch-repair deficiency commonly found in solid tumors. In addition to the colorectal... Read more